CSL Ltd
ASX:CSL
CSL Ltd
Pre-Tax Income
CSL Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Pre-Tax Income
$3.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Immutep Ltd
ASX:IMM
|
Pre-Tax Income
-AU$40.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
Mesoblast Ltd
ASX:MSB
|
Pre-Tax Income
-$73.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Pre-Tax Income
AU$45.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Pre-Tax Income
AU$3.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Pre-Tax Income
-AU$21.7m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-17%
|
See Also
What is CSL Ltd's Pre-Tax Income?
Pre-Tax Income
3.1B
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Pre-Tax Income amounts to 3.1B USD.
What is CSL Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
8%
Over the last year, the Pre-Tax Income growth was 18%. The average annual Pre-Tax Income growth rates for CSL Ltd have been -2% over the past three years , 6% over the past five years , and 8% over the past ten years .